Cohort information

ITALY				WP2
Organization		UNIBO
Name of cohort		UNIBO WP2 Prospective
Referring partner		UNIBO
Cohort Information	Country(-ies), cities, regions or centers involved	Bologna, Italy
	Time of data collection	07/2021	Ongoing
	Enrolment	Inactive
	Study setting	Single center
Population	Age	Adults,Elderly
	Type	Prospective
	Total number of patients	428
	Site of enrolment (WP2)	Outpatient,Inpatient
Data collection	Clinical data	True
	Serological data	True
	Genetic data	True
	Sample collection	True
	Sample collected	Whole blood	Yes
		PBMC	Yes
		Dry-spot blood	No
		Plasma	Yes
		Serum	Yes
		Stool	Yes
		NP swabs	Yes
		Other	None
Description	Prospective cohort study enrolling hospitalized and non-hospitalized patients with a diagnosed SARS-CoV-2 infection. Main objectives: describe characteristics of COVID-19 sequelae, including type, rate, and length through clinical, laboratory, and radiological assessments; investigate valuable, confounder-adjusted, associations between COVID-19 sequelae and COVID-19 severity, comorbidities, aetiology (SARS-CoV-2 variants), COVID treatment (including monoclonal antibodies), and trends in SARS-CoV-2 antibodies; describe the rate, the aetiology (SARS-CoV-2 variants), severity, and clinical determinants of COVID-19 re-infections.
Publications	- SARS-CoV-2 Breakthrough Infections in Health Care Workers: An Italian Retrospective Cohort Study on Characteristics, Clinical Course and Outcomes [Journal of Clinical Medicine]